Cargando…
High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome
Ovarian cancer (OC) is the most lethal gynecological malignancy, with platinum‐based chemotherapy remaining the mainstay for adjuvant treatment after surgery. The lack of indication for immunotherapy may at least in part result from the lack of suitable biomarkers allowing stratification of potentia...
Autores principales: | Wolf, Dominik, Fiegl, Heidi, Zeimet, Alain G., Wieser, Verena, Marth, Christian, Sprung, Susanne, Sopper, Sieghart, Hartmann, Gunther, Reimer, Daniel, Boesch, Maximilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028124/ https://www.ncbi.nlm.nih.gov/pubmed/31800094 http://dx.doi.org/10.1002/ijc.32818 |
Ejemplares similares
-
Evaluation of Vav3.1 as prognostic marker in endometrial cancer
por: Boesch, Maximilian, et al.
Publicado: (2018) -
High prevalence of side population in human cancer cell lines
por: Boesch, Maximilian, et al.
Publicado: (2016) -
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
por: Boesch, Maximilian, et al.
Publicado: (2014) -
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Leitner, Katharina, et al.
Publicado: (2020) -
High number of kinome‐mutations in non‐small cell lung cancer is associated with reduced immune response and poor relapse‐free survival
por: Helland, Å., et al.
Publicado: (2017)